Skip to content

Comparison of comfort and complications in patients of implantable venous access port (IVAP) with B ultrasound guided subclavian vein (SCV) puncture and axillary vein / internal jugular vein (IJV) puncture: a prospective randomized controlled study

Comparison of comfort and complications in patients of implantable venous access port (IVAP) with B ultrasound guided subclavian vein (SCV) puncture and axillary vein / internal jugular vein (IJV) puncture: a prospective randomized controlled study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034986
Enrollment
Unknown
Registered
2020-07-26
Start date
2020-07-20
Completion date
Unknown
Last updated
2020-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

IJV group:implantation infusion port with IJV
axillary vein/SCV group:implantation infusion port with SCV

Sponsors

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Female patients with pathologically diagnosed breast cancer, including invasive ductal carcinoma, invasive lobular carcinoma and other types of breast cancer; Lobular neoplasm, lobular carcinoma in situ and ductal carcinoma in situ without infiltrating foci were excluded. 2. Intravenous adjuvant or neoadjuvant chemotherapy is proposed. 3. Consent to infusion port implantation.

Exclusion criteria

Exclusion criteria: 1. Advanced breast cancer patients; 2. The patient had a history of venous thrombosis.

Design outcomes

Secondary

MeasureTime frame
Complications after infusion port implantation;

Primary

MeasureTime frame
comfort;

Countries

China

Contacts

Public ContactWu Jiannan

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University

king8702@163.com+86 13631374398

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 17, 2026